EUVIMEDEUVIMED entdecken
Crossref

Skin cancer in renal transplant recipients: outcomes from a safety net hospital in Boston

Dilshad Sachedina iD, Frederick Gibson, Eric Xia, Anika Walia, Laxmi Behara, Sherwin Fazelpour, Haley Mullins, Jean Francis, Debjani Sahni

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Dilshad Sachedina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Boston University School of Medicine, Boston, MA, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Skin Neoplasms, Melanoma, Basal Cell Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal transplant recipients (RTRs) are prone to skin cancer due to the immunosuppression required to maintain graft function. Existing studies of skin cancer in RTRs focus on patients with Fitzpatrick skin types I‐II, with limited documentation of incidence in skin types III‐VI. This study seeks to better characterize skin cancers in RTRs with skin types III‐VI. Primary aims Compare the incidence of skin cancer in RTRs of skin types I‐II with skin types III‐VI. Secondary aims Explore the association between the development of skin cancer and other contributing factors in RTRs of skin types I‐VI.

Methods

Retrospective chart review of RTRs at a single institution between January 1, 2000 and December 31, 2022. Patients were followed from the date of transplant to the last clinical follow‐up or death. 777 RTRs were included in the study, including 245 patients with Fitzpatrick skin types I‐II and 532 with skin types III‐VI. A total of 48 patients developed NMSCs, 2 patients developed melanoma, and 3 patients developed Kaposi sarcoma. Results and conclusions There is a higher incidence of skin cancer in RTRs with Fitzpatrick skin types III‐VI compared to the reported incidence among non‐transplant recipients of the same skin types, but the incidence remains considerably lower compared to RTR of skin types I‐II.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationSkin NeoplasmsMelanomaBasal Cell CarcinomaSarcoma, KaposiHumansMaleFemaleRetrospective StudiesMiddle AgedIncidenceAdultBostonAgedSafety-net ProvidersTransplant RecipientsCarcinoma, Squamous CellImmunosuppressive Agents

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Boston University School of Medicine, Boston, MA, USA.
  • Department of Nephrology, Boston University School of Medicine, Boston, MA, USA.

ORCID-Profile: Dilshad Sachedina

Zitieren

APA

Sachedina, D., Gibson, F., Xia, E., Walia, A., Behara, L., Fazelpour, S., Mullins, H., Francis, J., & Sahni, D. (2024). Skin cancer in renal transplant recipients: outcomes from a safety net hospital in Boston. International Journal of Dermatology. https://doi.org/10.1111/ijd.17061

Vancouver

Sachedina D, Gibson F, Xia E, Walia A, Behara L, Fazelpour S, et al. Skin cancer in renal transplant recipients: outcomes from a safety net hospital in Boston. International Journal of Dermatology. 2024. doi:10.1111/ijd.17061

BibTeX
@article{Sachedina2024,
  author = {Sachedina, Dilshad and Gibson, Frederick and Xia, Eric and Walia, Anika and Behara, Laxmi and Fazelpour, Sherwin and Mullins, Haley and Francis, Jean and Sahni, Debjani},
  title = {Skin cancer in renal transplant recipients: outcomes from a safety net hospital in Boston},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17061}
}
Kostenlos starten →